Novel Dosage Forms And Drug Delivery Technologies
Novel Dosage Forms And Drug Delivery Technologies
Main Contents 1 Introduction 2. Topical Administration 3. Oral Administration 4. Vaginal Administration 5. Ophthalmics 6. Parenteral Administration 7. Peglated Dosage Forms 8.Fusion Protein 9.Implants 10.Other Novel Delivery Systems
2 Main Contents • 1. Introduction • 2.Topical Administration • 3.Oral Administration • 4.Vaginal Administration • 5.Ophthalmics • 6.Parenteral Administration • 7.Peglated Dosage Forms • 8.Fusion Protein • 9.Implants • 10.Other Novel Delivery Systems
Introduction This chapter discusses novel drug delivery systems that are modifications of those previously presented, are relatively new on the market or do not fit into categories in previous chapters They may be relatively new, use new or relativel new delivery systems, or use unique delivery systems or unique devices before, during, or after administration
3 Introduction • This chapter discusses novel drug delivery systems that are modifications of those previously presented, are relatively new on the market, or do not fit into categories in previous chapters. • They may be relatively new, use new or relativel new delivery systems, or use unique delivery systems or unique devices before, during, or after administration
Introduction Changes are coming about as new technologies are developed and reduce the limitations of existing therapies In some cases, the new drugs require new delivery systems because the traditional systems are inefficient or ineffective this may be true especially of some of the recombinant dna and gene therapies of the future
4 Introduction • Changes are coming about as new technologies are developed and reduce the limitations of existing therapies. • In some cases, the new drugs require new delivery systems because the traditional systems are inefficient or ineffective; this may be true especially of some of the recombinant DNA and gene therapies of the future
Benefits: A)improvement of patients compliance; B)improved outcomes c reduction of adverse effects; D)improvement of patients' acceptance of the treatment E)avoidance of costly interventions such as laboratory services; F) allowing patients to receive medication as outpatients Ga reduction in the overall use of medicinal resources 5
5 Benefits: • A) improvement of patients’ compliance; • B) improved outcomes; • C) reduction of adverse effects; • D) improvement of patients’ acceptance of the treatment; • E) avoidance of costly interventions such as laboratory services; • F) allowing patients to receive medication as outpatients • G) a reduction in the overall use of medicinal resources